{"id":"W2573460873","doi":"10.1136/jnnp-2016-315106.143","title":"OCRELIZUMAB IN PRIMARY PROGRESSIVE MS: THE ORATORIO STUDY","year":2016,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Placebo; Medicine; Ocrelizumab; Clinical endpoint; Adverse effect; Internal medicine; Clinical trial; Surgery; Pathology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002137831,0.0008877965,0.001401753,0.0001650197,0.0002256512,0.0007447866,0.0005253194,0.001111875,0.003738662],"category_scores_gemma":[0.001157414,0.0001954176,0.001654191,0.0002885349,0.0003656489,0.0003865284,0.0003086801,0.00141807,0.000626113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005555575,"about_ca_system_score_gemma":0.0006366707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001221776,"about_ca_topic_score_gemma":0.002178858,"domain_scores_codex":[0.9994821,0.0002102186,0.00003324419,0.00009003718,0.00007735589,0.0001071336],"domain_scores_gemma":[0.9993308,0.0001451612,0.0002225496,0.00006769242,0.00006895541,0.0001648512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7479322,0.003672871,0.01699867,0.01108637,0.007898167,0.0005592371,0.000354816,0.001143377,0.01374253,0.0008014267,0.01989573,0.1759146],"study_design_scores_gemma":[0.7827073,0.09316792,0.07757739,0.001757669,0.01078841,0.001263717,0.0001209592,0.0008945094,0.001782042,0.000757963,0.02910531,0.00007675052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8596686,0.1143662,0.0004230486,0.002859395,0.0006772483,0.001139282,0.004319527,0.0001015808,0.01644507],"genre_scores_gemma":[0.9589282,0.02604725,0.000744479,0.004022735,0.0008710666,0.001124568,0.00304757,0.00003098067,0.005183199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003738662,"threshold_uncertainty_score":0.01250708,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01900507219427951,"score_gpt":0.3005907274350342,"score_spread":0.2815856552407547,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}